GoTo Telemed Launches Comprehensive Syphilis Management Program

KALISPELL, Mont. - May 18, 2026 - PRLog -- GoTo Telemed, the nation's leading integrated telehealth ecosystem serving over 10 million patients nationwide, today announced the launch of its comprehensive Syphilis Management Program, a dedicated virtual care initiative designed to help reverse the alarming resurgence of this preventable infection. The program integrates early, risk‑based screening; CDC‑recommended treatment; Doxy‑PEP for post‑exposure prophylaxis; expedited partner therapy; and coordinated prenatal care—all delivered through a secure, unified telehealth platform.

Syphilis has re‑emerged as a critical public health threat. Cases of congenital syphilis have skyrocketed 700% over the past decade, and nearly 4,000 newborns were infected in 2024 alone—a 12th consecutive year of increase. The U.S. Preventive Services Task Force has issued a Grade A recommendation reaffirming universal prenatal syphilis screening, yet access to timely testing and treatment remains highly uneven, especially for rural and underserved populations.

"Syphilis is entirely preventable, treatable, and—if missed—devastating for newborns," said a GoTo Telemed spokesperson. "Our Syphilis Management Program makes screening, CDC‑guideline treatment, partner services, and Doxy‑PEP accessible to everyone, regardless of where they live. By integrating these essential tools into a single virtual platform, we are helping to bend the curve of this preventable epidemic."

Guideline‑Aligned Screening and Staging

The program follows CDC and USPSTF screening recommendations. A non‑treponemal test (RPR or VDRL) is confirmed with a treponemal test (FTA‑ABS, TP‑PA, or EIA). Patients with a reactive result undergo a structured video consultation to classify the stage of infection according to CDC criteria:

Stage Key Features
Primary syphilis Painless chancre at the infection site; may be single or multiple
Secondary syphilis Rash, mucocutaneous lesions, lymphadenopathy
Early latent syphilis Seroreactive without clinical signs, acquired within prior 12 months
Late latent or unknown duration Seroreactive without clinical signs, acquired >12 months ago (or date unknown)
Tertiary (late) syphilis Cardiac involvement, gummas, tabes dorsalis, general paresis
CDC‑Recommended Treatment Pathways

Media Contact:
GoTo Telemed Media Relations
info@gototelemed.com
(660) 628-1660
https://gototelemed.com/